Critical Care

official impact factor 4.60

Open Access Highly Access

Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort

Richard V Hodder*, Richard Hall, James A Russell, Harold N Fisher and Bobbie Lee

Critical Care 2009, 13:R78 doi:10.1186/cc7893

Accesses  

  • Last 30 days: 43 accesses
  • Last 365 days: 592 accesses
  • All time: 3639 accesses

Cited by

BioMed Central: 1 citation

Research   Open Access Highly Accessed

Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice?

M Zia Sadique, Richard Grieve, David A Harrison, Brian H Cuthbertson, Kathryn M Rowan Critical Care 2011, 15:R228 (26 September 2011)